Evidence map›Paper›PMID 24642425›Full record

ReviewJournal of immunological methods2014

Visualizing hepatitis C virus infection in humanized mice.

Markus von Schaewen, Qiang Ding, Alexander Ploss

Abstract readReview
In one paragraph

Review in Journal of immunological methods, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Humanized Mouse Models of Clinical Disease.Annual review of pathology · 2017
    Review
  5. Role of apoptotic hepatocytes in HCV dissemination: regulation by acetaldehyde.American journal of physiology. Gastrointestinal and liver physiology · 2016
    Article
  6. Article
  7. Application of Humanized Mice in Immunological Research.Methods in molecular biology (Clifton, N.J.) · 2016
    Review
  8. Orthotopic transplantation of decellularized liver scaffold in mice.International journal of clinical and experimental medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Markus von SchaewenDepartment of Molecular Biology, Princeton University, 110 Lewis Thomas Laboratory, Washington Road, Princeton, NJ 08544, United States.
Qiang DingDepartment of Molecular Biology, Princeton University, 110 Lewis Thomas Laboratory, Washington Road, Princeton, NJ 08544, United States.
Alexander PlossDepartment of Molecular Biology, Princeton University, 110 Lewis Thomas Laboratory, Washington Road, Princeton, NJ 08544, United States. Electronic address: aploss@princeton.edu.

Funding

Genetic Viral and Host Adaptations to Breach Species Barriers of HCVR01AI107301 · NIAID · PRINCETON UNIVERSITY · PI Thomas Pietschmann, Alexander Ploss · 2013 to 2026
$6.0M
Understanding human neutralizing antibodies to hepatitis C virusR01AI079031 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI LAW, MANSUN · 2008 to 2017
$4.6M
Dissecting virus neutralizing determinants to guide HCV vaccine developmentR56AI106005 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI LAW, MANSUN · 2013 to 2013
$793k
Transmitted/Founder HCV clones as targets for treatment and eradication.R21AI106000 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI PLOSS, ALEXANDER, RICE, CHARLES M · 2013 to 2014
$452k
NIAID NIH HHS 1 R01 AI107301-01NIAID NIH HHS 1R21 AI 106000-01NIAID NIH HHS 1 R56 AI106005-01NIAID NIH HHS 2 R01 AI079031-05A1NIAID NIH HHS R01 AI079031NIAID NIH HHS R01 AI107301NIAID NIH HHS R21 AI106000NIAID NIH HHS R56 AI106005
6 · The paper itself

Abstract

Hepatitis C virus (HCV) establishes frequently persistent infections. Chronic carriers can develop severe liver disease. HCV has been intensely studied in a variety of cell culture systems. However, commonly used cell lines and primary hepatocyte cultures do not or only in part recapitulate the intricate host environment HCV faces in the liver. HCV infects readily only humans and chimpanzees, which poses challenges in studying HCV infection in vivo. Consequently, tractable small animal models are needed that are not only suitable for analyzing HCV infection but also for testing novel therapeutics. Here, we will focus our discussion on humanized mice, i.e. mice engrafted with human tissues or expressing human genes, which support HCV infection. We will further highlight novel methods that can be used to unambiguously detect HCV infected cells in situ, thereby facilitating a spatio-temporal dissection of HCV infection in the three dimensional context of the liver.

Indexed as

Disease Models, AnimalHepacivirusHepatitis C, ChronicHepatocytesLiverAnimalsHumansMiceAnimal modelHepatitis C virusHumanized miceImagingViral hepatitis

Identifiers

PMID24642425
PMCPMC4163068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.